182 related articles for article (PubMed ID: 31352989)
1. Histiocytic and Dendritic Cell Neoplasms.
Pan Z; Xu ML
Surg Pathol Clin; 2019 Sep; 12(3):805-829. PubMed ID: 31352989
[TBL] [Abstract][Full Text] [Related]
2. Descriptive Analysis of Histiocytic and Dendritic Cell Neoplasms: A Single-Institution Experience.
Kim HM; Yang WI; Lyu CJ; Hahn SM; Yoon SO
Yonsei Med J; 2020 Sep; 61(9):774-779. PubMed ID: 32882761
[TBL] [Abstract][Full Text] [Related]
3. High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms.
Huang W; Qiu T; Zeng L; Zheng B; Ying J; Feng X
Oncotarget; 2016 Nov; 7(48):78355-78362. PubMed ID: 27823979
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell and histiocytic neoplasms: biology, diagnosis, and treatment.
Dalia S; Shao H; Sagatys E; Cualing H; Sokol L
Cancer Control; 2014 Oct; 21(4):290-300. PubMed ID: 25310210
[TBL] [Abstract][Full Text] [Related]
5. The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms.
Dorfman DM; Hornick JL; Shahsafaei A; Freeman GJ
Hum Pathol; 2010 Oct; 41(10):1486-94. PubMed ID: 20656318
[TBL] [Abstract][Full Text] [Related]
6. Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.
Go H; Jeon YK; Huh J; Choi SJ; Choi YD; Cha HJ; Kim HJ; Park G; Min S; Kim JE
Histopathology; 2014 Aug; 65(2):261-72. PubMed ID: 24720374
[TBL] [Abstract][Full Text] [Related]
7. Histiocytic and dendritic neoplasms.
Skoog L; Tani E
Monogr Clin Cytol; 2009; 18():56-9. PubMed ID: 19092263
[No Abstract] [Full Text] [Related]
8. [Histiocytic diseases in childhood and adolescence].
Vokuhl C; Oschlies I; Klapper W; Leuschner I
Pathologe; 2015 Sep; 36(5):443-50. PubMed ID: 26292932
[TBL] [Abstract][Full Text] [Related]
9. Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases.
Berres ML; Allen CE; Merad M
Adv Immunol; 2013; 120():127-61. PubMed ID: 24070383
[TBL] [Abstract][Full Text] [Related]
10. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.
Pileri SA; Grogan TM; Harris NL; Banks P; Campo E; Chan JK; Favera RD; Delsol G; De Wolf-Peeters C; Falini B; Gascoyne RD; Gaulard P; Gatter KC; Isaacson PG; Jaffe ES; Kluin P; Knowles DM; Mason DY; Mori S; Müller-Hermelink HK; Piris MA; Ralfkiaer E; Stein H; Su IJ; Warnke RA; Weiss LM
Histopathology; 2002 Jul; 41(1):1-29. PubMed ID: 12121233
[TBL] [Abstract][Full Text] [Related]
11. [Reactive and neoplastic histiocytic diseases in the dog].
Schwens Ch; Thom N; Moritz A
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2011; 39(3):176-90. PubMed ID: 22143627
[TBL] [Abstract][Full Text] [Related]
12. Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.
Facchetti F; Pileri SA; Lorenzi L; Tabanelli V; Rimsza L; Pittaluga S; Dirnhofer S; Copie-Bergman C; de Leval L; Rosenwald A; Wotherspoon A; Fend F
Virchows Arch; 2017 Oct; 471(4):467-489. PubMed ID: 28695297
[TBL] [Abstract][Full Text] [Related]
13. Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling.
Tian X; Xu J; Fletcher C; Hornick JL; Dorfman DM
Mod Pathol; 2018 Apr; 31(4):553-561. PubMed ID: 29327713
[TBL] [Abstract][Full Text] [Related]
14. Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016.
Tzankov A; Kremer M; Leguit R; Orazi A; van der Walt J; Gianelli U; Hebeda KM
Ann Hematol; 2018 Nov; 97(11):2117-2128. PubMed ID: 30084011
[TBL] [Abstract][Full Text] [Related]
15. Expression of the transcription factor ZBTB46 distinguishes human histiocytic disorders of classical dendritic cell origin.
Satpathy AT; Brown RA; Gomulia E; Briseño CG; Mumbach MR; Pan Z; Murphy KM; Natkunam Y; Chang HY; Kim J
Mod Pathol; 2018 Sep; 31(9):1479-1486. PubMed ID: 29743654
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of the histiocytoses: Neoplasia of dendritic cells and macrophages.
Durham BH
Semin Cell Dev Biol; 2019 Feb; 86():62-76. PubMed ID: 29526544
[TBL] [Abstract][Full Text] [Related]
17. Histiocytic sarcoma with interdigitating dendritic cell differentiation.
Porter DW; Gupte GL; Brown RM; Spray C; English MW; deVille DeGoyet J; McKiernan PJ
J Pediatr Hematol Oncol; 2004 Dec; 26(12):827-30. PubMed ID: 15591905
[TBL] [Abstract][Full Text] [Related]
18. Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs.
Affolter VK; Moore PF
Vet Pathol; 2002 Jan; 39(1):74-83. PubMed ID: 12102221
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case series.
Saygin C; Uzunaslan D; Ozguroglu M; Senocak M; Tuzuner N
Crit Rev Oncol Hematol; 2013 Nov; 88(2):253-71. PubMed ID: 23755890
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years.
Dalia S; Jaglal M; Chervenick P; Cualing H; Sokol L
Cancers (Basel); 2014 Nov; 6(4):2275-95. PubMed ID: 25405526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
